EGFR and psychiatric disorder: The direct evidence provided by the present study that gain of function in ErbB receptors caused primary white matter lesions emphasizes that monitoring white matter in live patients and testing the genetic variability of ErbB signaling pathways are two necessary methods to help develop prognostic and therapeutic strategies for psychiatric disorders.